Electrophysiology of neuromuscular disorders in critical illness

Muscle and Nerve

Volumn 47, Issue 3, 2013, Pages 452-463

  Lacomis, David ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Critical illness myopathy; Critical illness polyneuropathy; Intensive care unit; Myopathy; Neuromuscular disorders; Polyneuropathy

Indexed keywords

ARTICLE; BRAIN ELECTROPHYSIOLOGY; CRITICAL ILLNESS; CRITICAL ILLNESS MYOPATHY; CRITICAL ILLNESS POLYNEUROPATHY; ELECTRODE; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; HUMAN; INTENSIVE CARE UNIT; MUSCLE ACTION POTENTIAL; MUSCLE EXCITATION; MUSCLE WEAKNESS; MYOPATHY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR WEAKNESS; POLYNEUROPATHY; PRIORITY JOURNAL; RISK FACTOR; SENSORIMOTOR POLYNEUROPATHY; TREATMENT INDICATION;

ANIMALS; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; INTENSIVE CARE; MUSCLE WEAKNESS; MUSCULAR DISEASES; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR DISEASES; POLYNEUROPATHIES; TREATMENT OUTCOME;

EID: 84874285042     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23615     Document Type: Article

References (118)

1. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47:1223-1231.
2. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1986;49:563-573.
3. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110:819-841.
4. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-184.
5. Zifko UA, Zipko HT, Bolton CF. Clinical and electrophysiological findings in critical illness polyneuropathy. J NeurolSci 1998;159:186-193.
6. Ferrante M. Brachial plexopathies: classification, causes, and consequences. Muscle Nerve 2004;30:547-568.
7. Dawson DM, Krarup C. Perioperative nerve lesions. Arch Neurol 1989;46:1355-1360.
8. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998;21:610-617.
9. Rosenow EC III, Engel AG. Acid maltase deficiency in adults presenting as respiratory failure. Am J Med 1978;64:485-491.
10. Hughes RA, Bihari D. Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatry 1993;56:334-343.
11. Kelly BJ, Luce JM. The diagnosis and management of neuromuscular diseases causing respiratory failure. Chest 1991;99:1485-1494.
12. O'Donohue WJ Jr, Baker JP, Bell GM, Muren O, Parker CL, Patterson JL Jr. Respiratory failure in neuromuscular disease. Management in a respiratory intensive care unit. JAMA 1976;235:733-735.
13. Abdel-Hamid H, Oddis CV, Lacomis D. Severe hydroxychloroquine myopathy. Muscle Nerve 2008;38:1206-1210.
14. Souayah N, Sander HW, Menkes DL, Khella SL. Hepatitis C virus acute quadriparetic vasculitic neuropathy responsive to cyclophosphamide. Neurol Neurophysiol Neurosci 2006;18:5.
15. Newman JH, Neff TA, Ziporin P. Acute respiratory failure associated with hypophosphatemia. N Engl J Med 1997;296:1101-1103.
16. Bruno C, Sacco O, Santorelli FM, Assereto S, Tonoli E, Bado M, et al. Mitochondrial myopathy and respiratory failure associated with a new mutation in the mitochondrial transfer ribonucleic acid glutamic acid gene. J Child Neurol 2003;18:300-303.
17. Gorson KC, Ropper AH. Nonpoliovirus poliomyelitis simulating Guillain-Barre syndrome. Arch Neurol 2001;58:1460-1464.
18. Spitzer AR, Giancarlo T, Maher L, Awerbuch G, Bowles A. Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve 1992;15:682-686.
19. Al-Shekhlee A, Shapiro BE, Preston DC. Iatrogenic complications and risks of nerve conduction studies and needle electromyography. Muscle Nerve 2003;27:517-526.
20. Lacomis D. Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromusc Dis 2011;12:197-218.
21. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005;32:140-163.
22. Campellone JV. Clinical approach to neuromuscular weakness in the critically ill patient. J Clin Neuromuscul Dis 2000;1:151-158.
23. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007;33:1876-1891.
24. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, et al. Critical illness myopathy and neuropathy. Lancet 1996;347:1579-1582.
25. Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care 2005;11:381-390.
26. Russell JA. Management of sepsis. N Engl J Med 2006;355:1699-1713.
27. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-1655.
28. Coakley JH, Nagendran K, Honavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993;19:323-328.
29. Coakley JH, Nagendran K, Yarwood GD, Hinds CJ. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 1998;24:801-807.
30. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-2867.
31. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006;67:1421-1425.
32. Latronico N, Bertolini G, Guarneri B, Botteri M, Peli E, Andreoletti S, et al. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care 2007;11:R11.
33. Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1996;22:849-855.
34. Hough CL, Steinberg KP, Taylor Thompson B, Rubenfeld GD, Hudson LD. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med 2009;35:63-68.
35. Leijten FS, De Weerd AW, Poortvliet DC. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 1996;22:856-861.
36. Tepper M, Rakic S, Haas JA, Woittiez AJ. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 2000;56:211-214.
37. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27:1288-1296.
38. Druschky A, Herkert M, Radespiel-Troger M, Druschky K, Hund E, Becker CM, et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001;27:686-693.
39. Thiele RI, Jakob H, Hund E, Tantzky S, Keller S, Kamler M, et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery. Thorac Cardiovasc Surg 2000;48:145-150.
40. Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol 2005;252:343-351.
41. de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001;29:2281-2286.
42. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD, Weinmann M, Czarny D, et al. Myopathy in severe asthma. Am Rev Respir Dis 1992;146:517-519.
43. Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani MJ. Acute myopathy after liver transplantation. Neurology 1998;50:46-53.
44. Amaya-Villar R, Garnacho-Montero J, Garcia-Garmendia JL, Madrazo-Osuna J, Garnacho-Montero MC, Luque R, et al. Steroid-inducedmyopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2005;31:157-161.
45. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
46. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
47. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64:1348-1353.
48. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medicalintensive care unit. Am J RespirCrit Care Med 2007;175:480-489.
49. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
50. de Seze M, Petit H, Wiart L, Cardinaud JP, Gaujard E, Joseph PA, et al. Critical illness polyneuropathy. A 2-year follow-up study in 19 cases. Eur Neurol 2000;43:61-69.
51. Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 2010;14:R119.
52. Hoke A, Rewcastle NB, Zochodne DW. Acute quadriplegic myopathy unrelated tosteroids or paralyzing agents: quantitative EMG studies. Can J Neurol Sci 1999;26:325-239.
53. Deconinck N, Van Parijs V, Beckers-Bleukx G, Van den Bergh P. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 1998;8:186-192.
54. Sander HW, Golden M, Danon MJ. Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle Nerve 2002:26;499-505.
55. Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J RespirCrit Care Med 1996;153:1686-1690.
56. Blackie JD, Gibson P, Murree-Allen K, Saul WP. Acute myopathy in status asthmaticus. Clin Exp Neurol 1993;30:72-81.
57. Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992;102:510-514.
58. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996;40:645-654.
59. Sitwell LD, Weinshenker BG, Monpetit V, Reid D. Complete ophthalmoplegia as a complication of acute corticosteroid- and pancuronium-associated myopathy. Neurology 1991;41:921-922.
60. Shee CD. Risk factors for hydrocortisone myopathy in acute severe asthma. Respir Med 1990;84:229-233.
61. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992;327:524-528.
62. Segredo V, Matthay MA, Sharma ML, Gruenke LD, Caldwell JE, Miller RD. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology 1990;72:566-570.
63. Kupfer Y, Namba T, Kaldawi E, Tessler S. Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med 1992;117:484-486.
64. Gooch JL. AANEM Case Report #29. Prolonged paralysis after neuromuscular blockade. Muscle Nerve 1995;18:937-942.
65. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994;17:647-654.
66. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994;17:285-292.
67. Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, Herbrink P, et al. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology 2010;74:581-587.
68. Keesey JC. Electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve 1989;12:613-626.
69. Al-Shekhlee A, Hachwi R, Jaberi MM, Katirji B. The electromyographic features of acute rhabdomyolysis. J Clin Neuromuscul Dis 2005;6:114-118.
70. Faragher MW, Day BJ, Dennett X. Critical care myopathy: an electrophysiologicaland histological study. Muscle Nerve 1996;19:516-518.
71. Hanson P, Dive A, Brucher JM, Bisteau M, Dangoisse M, Deltombe T. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997;20:1371-1380.
72. Case Records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11- 1997. A 51-year-old man with chronic obstructive pulmonary disease and generalized muscle weakness. N Engl J Med 1997:336:1079-1088.
73. Park EJ, Nishida T, Sufit RL, Minieka MM. Prolonged compound muscle action potential duration in critical illness myopathy. Report of nine cases. J Clin Neuromuscul Dis 2004;5:176-183.
74. Goodman BP, Harper CM, Boon AJ. Prolonged compound muscle action potential duration in critical illness myopathy. Muscle Nerve 2009:40:1040-1042.
75. Bednarik J, Lukas Z, Vondracek. Critical illness polyneuromyopathy: the electrophysiologic components of a complex entity. Intensive Care Med 2003;29:1505-1514.
76. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731-736.
77. Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy-a reappraisal. Clin Neurophysiol 2001;112:1586-1593.
78. Lefaucher JP, Nordine T, Rodriguez P, Brochard L. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 2006;77:500-506.
79. Seghelini E. Direct stimulation: a useful technique. Eur J Anaesthesiol Suppl 2008;42:181-185.
80. Allen DC, Arunachalam R, Mills KR. Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy. Muscle Nerve 2008;37:14-22.
81. Z'Graggen WJ, Brander L, Tuchscherer D, Scheidegger O, Takala J, Bostock H. Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles. Clin Neurophysiol 2011;122:834-841.
82. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997;20:665-673.
83. Road J, Mackie G, Jiang TX, Stewart H, Eisen A. Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiological correlates. Muscle Nerve 1997;20:1587-1590.
84. Hund E, Genzwurker H, Bohrer H, Jakob H, Thiele R, Hacke W. Predominant involvement of motor fibers in patients with critical illness polyneuropathy. Br J Anaesthesia 1997;78:274-278.
85. Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000;26:1360-1363.
86. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, Argentini C, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 2000;28:34-45.
87. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-1139.
88. Waclawik AJ, Sufit RL, Beinlich BR, Schutta HS. Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium. Neuromuscul Disord 1992;2:19-26.
89. Ahlbeck K, Fredriksson K, Rooyackers O, Maback G, Remahl S, Ansved T, et al. Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course. Acta Anaesthesiol Scand 2009;53:717-723.
90. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-322.
91. Matsumoto N, Nakamura T, Yasui Y, Torii J. Analysis of muscle proteins in acute quadriplegic myopathy. Muscle Nerve 2000;23:1270-1276.
92. Waclawik AJ, Selcen D, Keegan BM. A 46-year-old woman with severe weaknessfollowing acute respiratory distress syndrome. Neurology 2007;68:1529-1535.
93. Di Giovanni S, Mirabella M, D'Amico A, Tonali P, Servidei S. Apoptotic features accompany acute quadriplegic myopathy. Neurology 2000;55:854-858.
94. Di Giovanni S, Molon A, Broccolini A, Melcon G, Mirabella M, Hoffman EP, et al. Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 2004:55:195-206.
95. Capasso M, Di Muzio A, Pandolfi A, Pace M, Di Tomo P, Ragno M, et al. Possible role for nitric oxide dysregulation in critical illness myopathy. Muscle Nerve 2008;37:196-202.
96. Lanone S, Mebazaa A, Heymes C, Henin D, Poderoso JJ, Panis Y, et al. Muscular contractile failure in septic patients. Role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med 2000;162:2308-2315.
97. Legerlotz K, Smith HK. Role of MyoD in denervated, disused, and exercised muscle. Muscle Nerve 2008;38:1087-1100.
98. Talmadge RJ. Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerve 2000;23:661-679.
99. Rouleau G, Karpati G, Carpenter S, Soza M, Prescott S, Holland P. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 1987;10:428-438.
100. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 1992;15:1290-1298.
101. Rich MM, Pinter MJ, Kramer SD, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998;43:171-179.
102. Friedrich O, Hund E, von Wegner F. Enhanced muscle shortening and impaired Ca2+ channel function in an acute septic myopathy model. J Neurol 2010;257:546-555.
103. Kraner SD, Wang Q, Novak KR, Cheng D, Cool DR, Peng J, et al. Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy. Am J Physiol Regul Integr Comp Physiol 2011;300:R1384-R1391.
104. Hund E, Herkert M, Becker CM, Hacke W. A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy. Ann Neurol 1996;40:539.
105. Friedrich O, Fink RA, Hund E. Understanding critical illness myopathy: approaching the pathomechanism. J Nutr 2005;135:1813S-1817S.
106. Rossignol B, Gueret G, Pennec JP, Morel J, Giroux-Metges MA, Talarmin H, et al. Effects of chronic sepsis on the voltage-gated sodium channel in isolated rat muscle fibers. Crit Care Med 2007;35:351-357.
107. Novak KR, Nardelli P, Cope TC, Filatov G, Glass JD, Khan J, et al. Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 2009;119:1150-1158.
108. Wieske L, Harmsen RE, Schultz MJ, Horn J. Is critical illness neuromyopathy and duration of mechanical ventilation decreased by strict glucos control? Neurocrit Care 2011;14:475-481.
109. Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al. Electrical muscle stimulation prevents criticalillness polyneuromyopathy: a randomized parallelintervention trial. Crit Care 2010;14:R74.
110. Williams TJ, O'Hehir RE, Czarny D, Horne M, Bowes G. Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. Am Rev Respir Dis 1988;137:460-463.
111. Chawla J, Gruener G. Management of critical illness polyneuropathy and myopathy. Neurol Clin 2010;28:961-977.
112. Doherty N, Steen CD. Critical illness polyneuromyopathy (CIPNM); rehabilitation during critical illness. Therapeutic options in nursing to promote recovery: a review of the literature. Intensive Crit Care Nurs 2010;26:353-362.
113. Koch S, Spuler S, Deja M, Bierbrauer J, Dimroth A, Behse F, et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 2011;82:287-293.
114. Intiso D, Amoruso L, Zarrelli M, Pazienza L, Basciani M, Grimaldi G, et al. Long-term functional outcome and health status of patients with critical illness polyneuromyopathy. Acta Neurol Scand 2011;123:211-219.
115. Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 2008;79:838-841.
116. Trojaborg W, Kaufmann P, Gooch CL. Motor unit estimate number in the anterior tibial muscle: normative data versus findings in critically ill patients in intensive care units. J Clin Neuromuscul Dis 2002;3:139-142.
117. Lacomis D, Zochodne D, Bird SJ. Critical illness myopathy [Editorial]. Muscle Nerve 2000;23:1785-1788.
118. Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009;37(Suppl):S299-S300.